Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients.
about
Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis.Pharmacological aspects and spectrum of action of ceftazidime-avibactam: a systematic review.Population pharmacokinetics and dosing optimisation of ceftazidime in infants.Assessment of Ceftazidime-Avibactam 30/20 μg Disk Content Versus MIC Results When Tested against Enterobacteriaceae and Pseudomonas aeruginosa.Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016.
P2860
Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase I Study Assessing the Ph ...... spitalized Pediatric Patients.
@en
Phase I Study Assessing the Ph ...... spitalized Pediatric Patients.
@nl
type
label
Phase I Study Assessing the Ph ...... spitalized Pediatric Patients.
@en
Phase I Study Assessing the Ph ...... spitalized Pediatric Patients.
@nl
prefLabel
Phase I Study Assessing the Ph ...... spitalized Pediatric Patients.
@en
Phase I Study Assessing the Ph ...... spitalized Pediatric Patients.
@nl
P2093
P2860
P356
P1476
Phase I Study Assessing the Ph ...... ospitalized Pediatric Patients
@en
P2093
Antonio Arrieta
David Speicher
Deepa Mukundan
Diansong Zhou
Janice E Sullivan
Jianguo Li
John S Bradley
Jon Armstrong
José R Romero
Kathryn S Moffett
P2860
P304
P356
10.1128/AAC.00862-16
P407
P50
P577
2016-09-23T00:00:00Z